News

Filter

1 to 9 of 250 results

ABPI Rheumatology Initiative report says the UK does not prioritize rheumatoid arthritis enough

ABPI Rheumatology Initiative report says the UK does not prioritize rheumatoid arthritis enough

04-03-2015

Rheumatoid arthritis is not given a high enough priority in the UK, according to a new report from the…

Anti-Arthritics/RheumaticsMarkets & MarketingPharmaceuticalResearchSocial IssuesUK

Targeted lung cancer therapies supplanting conventional drugs; report

03-03-2015

Although lung cancer is the third most prevalent cancer type in the world, there are only 18 drugs in…

AstraZenecaBristol-Myers SquibbEli LillyMarkets & MarketingMerck & ConecitumumabOncologyOpdivoPharmaceuticalResearchRoche

Ferring launches Cortiment in Europe and publishes new efficacy data

Ferring launches Cortiment in Europe and publishes new efficacy data

20-02-2015

Switzerland-headquartered privately-held pharma company Ferring has announced the European launch Cortiment…

CortimentEuropeFerringGastro-intestinalsMarkets & MarketingPharmaceuticalResearch

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

England's cancer outcomes worse than rest of Europe: National Audit Office report

England's cancer outcomes worse than rest of Europe: National Audit Office report

16-01-2015

The UK’s National Audit Office has published a report, Progress in improving cancer services and outcomes…

Markets & MarketingOncologyPharmaceuticalPoliticsPricingResearchUK

Health care and pharma execs optimistic about business conditions in 2015: Economist report

Health care and pharma execs optimistic about business conditions in 2015: Economist report

14-01-2015

More than half of pharma and healt care executives expect business conditions for their company to improve…

GlobalMarkets & MarketingPharmaceuticalPricingProductionResearch

EffRx partners with Andrus to expand footprint Russia and CIS

14-01-2015

Swiss drug delivery specialist EffRx Pharmaceuticals has signed an agreement with Moscow-based Andrus…

AndrusEffRx PharmaceuticalsMarkets & MarketingPharmaceuticalResearchRussia

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

New drugs and biosimilars to drive rheumatoid arthritis to $19.3 billion by 2023

13-01-2015

The launch of novel drugs and biosimilars will drive steady growth in the global rheumatoid arthritis…

AmgenAnti-Arthritics/RheumaticsEnbrelHumiraMarkets & MarketingPharmaceuticalResearchUSA

1 to 9 of 250 results

COMPANY SPOTLIGHT

Menarini

Back to top